menu ☰
menu ˟

FDA approves HBV vaccine Heplisav-B for adults

10 Nov 2017
Dynavax announced that the FDA approved Heplisav-B, a recombinant hepatitis B vaccine, for all known subtypes of HBV in adults aged 18 years or older, according to a press release.William Schaffner Robert Janssen“Once physicians and public health i...

Click here to view the full article which appeared in Hepatology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.